Colorectal Neoplasms
Medicine & Life Sciences
100%
Stomach Neoplasms
Medicine & Life Sciences
46%
Neoplasms
Medicine & Life Sciences
37%
Survival
Medicine & Life Sciences
32%
Neoplasm Metastasis
Medicine & Life Sciences
30%
Colonic Neoplasms
Medicine & Life Sciences
27%
Taiwan
Medicine & Life Sciences
23%
Recurrence
Medicine & Life Sciences
19%
Huang, S. C. ,
Lin, C. C. ,
Teng, H. W. ,
Lin, H. H. ,
Chang, S. C. ,
Lan, Y. T. ,
Wang, H. S. ,
Yang, S. H. ,
Chen, W. S. &
Jiang, J. K. ,
17 3月 2022 ,
於: Frontiers in Oncology. 12 , 808808.
研究成果: Article › 同行評審
Taiwan
100%
Colorectal Neoplasms
80%
Vascular Endothelial Growth Factor A
60%
Survival
28%
Cetuximab
25%
Chang, Y-H. ,
Yang, H. J. ,
Chen, H. W. ,
Hsiao, C. W. ,
Hsieh, Y. C. ,
Chan, Y. W. ,
Chang, S. W. ,
Hwang, W-L. ,
Chen, W. S. ,
Cheng, H. H. ,
Chou, T. Y. ,
Chang, F. P. ,
Ho, H. L. ,
Chu, F. Y. ,
Lo, Y-L. ,
Chen, C. J. ,
Tsai, H. F. &
Shiau, M. Y. ,
1 2月 2022 ,
於: Cells. 11 ,
4 , 727.
研究成果: Article › 同行評審
collapsin response mediator protein-2
100%
Colorectal Neoplasms
46%
Comorbidity
46%
Diabetes Mellitus
21%
Proteins
11%
Lin, Y. Z. ,
Cheng, H. H. ,
Huang, S. C. ,
Chang, S. C. &
Lan, Y. T. ,
6月 2022 ,
於: ANZ Journal of Surgery. 92 ,
6 ,
p. 1466-1471 6 p. 研究成果: Article › 同行評審
Colonic Neoplasms
100%
Surgical Wound Infection
35%
Ileus
18%
Anastomotic Leak
18%
Survival
17%